nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—General Anesthesia—Propofol—epilepsy syndrome	0.432	1	CiPCiCtD
Ketamine—GRIN2A—epilepsy syndrome	0.0619	0.307	CbGaD
Ketamine—GRIN2B—epilepsy syndrome	0.0526	0.261	CbGaD
Ketamine—OPRD1—epilepsy syndrome	0.0441	0.219	CbGaD
Ketamine—GRIN2B—Felbamate—epilepsy syndrome	0.0409	0.184	CbGbCtD
Ketamine—GRIN2A—Felbamate—epilepsy syndrome	0.0409	0.184	CbGbCtD
Ketamine—OPRM1—epilepsy syndrome	0.0338	0.167	CbGaD
Ketamine—GRIN3A—Felbamate—epilepsy syndrome	0.0272	0.122	CbGbCtD
Ketamine—ABCB1—epilepsy syndrome	0.00933	0.0463	CbGaD
Ketamine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0049	0.0221	CbGbCtD
Ketamine—CYP2B6—Clobazam—epilepsy syndrome	0.00425	0.0192	CbGbCtD
Ketamine—CYP2C8—Trimethadione—epilepsy syndrome	0.00395	0.0178	CbGbCtD
Ketamine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00371	0.0168	CbGbCtD
Ketamine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00352	0.0159	CbGbCtD
Ketamine—PTGS1—Diazepam—epilepsy syndrome	0.0035	0.0158	CbGbCtD
Ketamine—CYP2B6—Primidone—epilepsy syndrome	0.00329	0.0148	CbGbCtD
Ketamine—CYP2B6—Phenytoin—epilepsy syndrome	0.00316	0.0143	CbGbCtD
Ketamine—ABCB1—Levetiracetam—epilepsy syndrome	0.00314	0.0142	CbGbCtD
Ketamine—CYP2B6—Propofol—epilepsy syndrome	0.00295	0.0133	CbGbCtD
Ketamine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00282	0.0127	CbGbCtD
Ketamine—CYP2B6—Midazolam—epilepsy syndrome	0.00278	0.0125	CbGbCtD
Ketamine—PTGS1—Valproic Acid—epilepsy syndrome	0.00276	0.0125	CbGbCtD
Ketamine—CYP2C9—Trimethadione—epilepsy syndrome	0.00275	0.0124	CbGbCtD
Ketamine—CYP2B6—Diazepam—epilepsy syndrome	0.00267	0.012	CbGbCtD
Ketamine—CYP2C8—Carbamazepine—epilepsy syndrome	0.00267	0.012	CbGbCtD
Ketamine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00259	0.0117	CbGbCtD
Ketamine—CYP2C8—Primidone—epilepsy syndrome	0.00249	0.0112	CbGbCtD
Ketamine—CYP2C8—Phenytoin—epilepsy syndrome	0.00239	0.0108	CbGbCtD
Ketamine—CYP2C8—Propofol—epilepsy syndrome	0.00223	0.0101	CbGbCtD
Ketamine—ABCB1—Clobazam—epilepsy syndrome	0.00218	0.00983	CbGbCtD
Ketamine—CYP2C8—Phenobarbital—epilepsy syndrome	0.00213	0.00962	CbGbCtD
Ketamine—CYP2B6—Valproic Acid—epilepsy syndrome	0.0021	0.00949	CbGbCtD
Ketamine—ABCB1—Lamotrigine—epilepsy syndrome	0.0021	0.00946	CbGbCtD
Ketamine—CYP2C8—Diazepam—epilepsy syndrome	0.00202	0.00912	CbGbCtD
Ketamine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00186	0.00839	CbGbCtD
Ketamine—ABCB1—Carbamazepine—epilepsy syndrome	0.00181	0.00815	CbGbCtD
Ketamine—CYP2C9—Primidone—epilepsy syndrome	0.00174	0.00784	CbGbCtD
Ketamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00172	0.00777	CbGbCtD
Ketamine—CYP2C9—Phenytoin—epilepsy syndrome	0.00167	0.00753	CbGbCtD
Ketamine—TACR1—vagus nerve—epilepsy syndrome	0.00164	0.0542	CbGeAlD
Ketamine—ABCB1—Phenytoin—epilepsy syndrome	0.00162	0.00731	CbGbCtD
Ketamine—CYP3A4—Trimethadione—epilepsy syndrome	0.0016	0.00723	CbGbCtD
Ketamine—CYP3A4—Felbamate—epilepsy syndrome	0.0016	0.00723	CbGbCtD
Ketamine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00159	0.00719	CbGbCtD
Ketamine—CYP2C9—Propofol—epilepsy syndrome	0.00156	0.00702	CbGbCtD
Ketamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00151	0.00679	CbGbCtD
Ketamine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00149	0.00671	CbGbCtD
Ketamine—ABCB1—Phenobarbital—epilepsy syndrome	0.00144	0.00651	CbGbCtD
Ketamine—ABCB1—Midazolam—epilepsy syndrome	0.00142	0.00642	CbGbCtD
Ketamine—CYP2C9—Diazepam—epilepsy syndrome	0.00141	0.00636	CbGbCtD
Ketamine—ABCB1—Diazepam—epilepsy syndrome	0.00137	0.00617	CbGbCtD
Ketamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00136	0.00614	CbGbCtD
Ketamine—CYP3A4—Clobazam—epilepsy syndrome	0.00131	0.00589	CbGbCtD
Ketamine—GRIN1—telencephalic ventricle—epilepsy syndrome	0.00111	0.0367	CbGeAlD
Ketamine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00111	0.00501	CbGbCtD
Ketamine—CYP3A4—Rufinamide—epilepsy syndrome	0.00111	0.00501	CbGbCtD
Ketamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00108	0.00488	CbGbCtD
Ketamine—GRIN2B—telencephalic ventricle—epilepsy syndrome	0.00106	0.035	CbGeAlD
Ketamine—CYP3A4—Primidone—epilepsy syndrome	0.00101	0.00456	CbGbCtD
Ketamine—CYP3A4—Phenytoin—epilepsy syndrome	0.000971	0.00438	CbGbCtD
Ketamine—CYP3A4—Propofol—epilepsy syndrome	0.000905	0.00408	CbGbCtD
Ketamine—SLC6A2—locus ceruleus—epilepsy syndrome	0.000871	0.0287	CbGeAlD
Ketamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.000865	0.0039	CbGbCtD
Ketamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.000865	0.0039	CbGbCtD
Ketamine—CYP3A4—Midazolam—epilepsy syndrome	0.000853	0.00385	CbGbCtD
Ketamine—CYP3A4—Diazepam—epilepsy syndrome	0.00082	0.0037	CbGbCtD
Ketamine—CYP3A4—Zonisamide—epilepsy syndrome	0.0008	0.00361	CbGbCtD
Ketamine—GRIN1—ganglion—epilepsy syndrome	0.000692	0.0228	CbGeAlD
Ketamine—GRIN2B—ganglion—epilepsy syndrome	0.000661	0.0218	CbGeAlD
Ketamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000646	0.00292	CbGbCtD
Ketamine—GRIN2C—hindbrain—epilepsy syndrome	0.000634	0.0209	CbGeAlD
Ketamine—TACR1—ganglion—epilepsy syndrome	0.000633	0.0209	CbGeAlD
Ketamine—GRIN2D—hindbrain—epilepsy syndrome	0.000589	0.0194	CbGeAlD
Ketamine—CYP3A4—Topiramate—epilepsy syndrome	0.000583	0.00263	CbGbCtD
Ketamine—GRIN2A—ganglion—epilepsy syndrome	0.000577	0.019	CbGeAlD
Ketamine—OPRM1—telencephalic ventricle—epilepsy syndrome	0.000564	0.0186	CbGeAlD
Ketamine—GRIN1—hindbrain—epilepsy syndrome	0.000525	0.0173	CbGeAlD
Ketamine—OPRD1—ganglion—epilepsy syndrome	0.000515	0.017	CbGeAlD
Ketamine—GRIN2B—hindbrain—epilepsy syndrome	0.000501	0.0165	CbGeAlD
Ketamine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000463	0.0153	CbGeAlD
Ketamine—GRIN2A—hindbrain—epilepsy syndrome	0.000438	0.0144	CbGeAlD
Ketamine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000376	0.0124	CbGeAlD
Ketamine—GRIN2C—brainstem—epilepsy syndrome	0.000363	0.012	CbGeAlD
Ketamine—OPRM1—ganglion—epilepsy syndrome	0.000351	0.0116	CbGeAlD
Ketamine—GRIN2C—forebrain—epilepsy syndrome	0.000351	0.0116	CbGeAlD
Ketamine—GRIN2D—brainstem—epilepsy syndrome	0.000338	0.0111	CbGeAlD
Ketamine—GRIN2D—forebrain—epilepsy syndrome	0.000326	0.0107	CbGeAlD
Ketamine—GRIN2C—telencephalon—epilepsy syndrome	0.000322	0.0106	CbGeAlD
Ketamine—GRIN3A—forebrain—epilepsy syndrome	0.000306	0.0101	CbGeAlD
Ketamine—GRIN1—brainstem—epilepsy syndrome	0.000301	0.00992	CbGeAlD
Ketamine—GRIN2D—telencephalon—epilepsy syndrome	0.0003	0.00988	CbGeAlD
Ketamine—GRIN1—forebrain—epilepsy syndrome	0.00029	0.00958	CbGeAlD
Ketamine—GRIN2B—brainstem—epilepsy syndrome	0.000287	0.00947	CbGeAlD
Ketamine—GRIN3A—telencephalon—epilepsy syndrome	0.000282	0.00929	CbGeAlD
Ketamine—GRIN2B—forebrain—epilepsy syndrome	0.000277	0.00914	CbGeAlD
Ketamine—TACR1—brainstem—epilepsy syndrome	0.000275	0.00908	CbGeAlD
Ketamine—GRIN1—telencephalon—epilepsy syndrome	0.000267	0.00881	CbGeAlD
Ketamine—TACR1—forebrain—epilepsy syndrome	0.000266	0.00876	CbGeAlD
Ketamine—SLC6A2—ganglion—epilepsy syndrome	0.000257	0.00847	CbGeAlD
Ketamine—GRIN2B—telencephalon—epilepsy syndrome	0.000255	0.0084	CbGeAlD
Ketamine—GRIN2C—medulla oblongata—epilepsy syndrome	0.000253	0.00835	CbGeAlD
Ketamine—GRIN2A—brainstem—epilepsy syndrome	0.000251	0.00827	CbGeAlD
Ketamine—TACR1—telencephalon—epilepsy syndrome	0.000244	0.00805	CbGeAlD
Ketamine—GRIN2A—forebrain—epilepsy syndrome	0.000242	0.00799	CbGeAlD
Ketamine—GRIN2D—medulla oblongata—epilepsy syndrome	0.000235	0.00776	CbGeAlD
Ketamine—DRD2—ganglion—epilepsy syndrome	0.000234	0.00772	CbGeAlD
Ketamine—GRIN2A—telencephalon—epilepsy syndrome	0.000223	0.00734	CbGeAlD
Ketamine—OPRD1—forebrain—epilepsy syndrome	0.000216	0.00712	CbGeAlD
Ketamine—GRIN2D—spinal cord—epilepsy syndrome	0.00021	0.00692	CbGeAlD
Ketamine—OPRK1—forebrain—epilepsy syndrome	0.000207	0.00682	CbGeAlD
Ketamine—GRIN2C—head—epilepsy syndrome	0.000201	0.00662	CbGeAlD
Ketamine—OPRD1—telencephalon—epilepsy syndrome	0.000199	0.00655	CbGeAlD
Ketamine—GRIN1—midbrain—epilepsy syndrome	0.000192	0.00632	CbGeAlD
Ketamine—GRIN2C—nervous system—epilepsy syndrome	0.00019	0.00627	CbGeAlD
Ketamine—GRIN1—spinal cord—epilepsy syndrome	0.000187	0.00617	CbGeAlD
Ketamine—GRIN2D—head—epilepsy syndrome	0.000187	0.00615	CbGeAlD
Ketamine—GRIN2C—central nervous system—epilepsy syndrome	0.000183	0.00604	CbGeAlD
Ketamine—GRIN2C—cerebellum—epilepsy syndrome	0.000179	0.0059	CbGeAlD
Ketamine—GRIN2B—spinal cord—epilepsy syndrome	0.000179	0.00589	CbGeAlD
Ketamine—DRD2—hindbrain—epilepsy syndrome	0.000178	0.00586	CbGeAlD
Ketamine—GRIN2D—nervous system—epilepsy syndrome	0.000177	0.00583	CbGeAlD
Ketamine—GRIN3A—head—epilepsy syndrome	0.000175	0.00578	CbGeAlD
Ketamine—GRIN2A—medulla oblongata—epilepsy syndrome	0.000175	0.00577	CbGeAlD
Ketamine—PTGS1—ganglion—epilepsy syndrome	0.000171	0.00564	CbGeAlD
Ketamine—TACR1—spinal cord—epilepsy syndrome	0.000171	0.00564	CbGeAlD
Ketamine—GRIN2D—central nervous system—epilepsy syndrome	0.00017	0.00562	CbGeAlD
Ketamine—GRIN2D—cerebellum—epilepsy syndrome	0.000166	0.00549	CbGeAlD
Ketamine—GRIN3A—nervous system—epilepsy syndrome	0.000166	0.00548	CbGeAlD
Ketamine—GRIN1—head—epilepsy syndrome	0.000166	0.00548	CbGeAlD
Ketamine—GRIN3A—central nervous system—epilepsy syndrome	0.00016	0.00528	CbGeAlD
Ketamine—GRIN2A—midbrain—epilepsy syndrome	0.00016	0.00527	CbGeAlD
Ketamine—GRIN2B—head—epilepsy syndrome	0.000159	0.00523	CbGeAlD
Ketamine—GRIN1—nervous system—epilepsy syndrome	0.000158	0.0052	CbGeAlD
Ketamine—GRIN2A—spinal cord—epilepsy syndrome	0.000156	0.00515	CbGeAlD
Ketamine—OPRM1—brainstem—epilepsy syndrome	0.000153	0.00503	CbGeAlD
Ketamine—TACR1—head—epilepsy syndrome	0.000152	0.00502	CbGeAlD
Ketamine—GRIN1—central nervous system—epilepsy syndrome	0.000152	0.00501	CbGeAlD
Ketamine—GRIN2B—nervous system—epilepsy syndrome	0.00015	0.00496	CbGeAlD
Ketamine—GRIN1—cerebellum—epilepsy syndrome	0.000148	0.00489	CbGeAlD
Ketamine—OPRM1—forebrain—epilepsy syndrome	0.000147	0.00485	CbGeAlD
Ketamine—GRIN2C—brain—epilepsy syndrome	0.000145	0.0048	CbGeAlD
Ketamine—GRIN2B—central nervous system—epilepsy syndrome	0.000145	0.00478	CbGeAlD
Ketamine—TACR1—nervous system—epilepsy syndrome	0.000144	0.00476	CbGeAlD
Ketamine—GRIN2B—cerebellum—epilepsy syndrome	0.000142	0.00467	CbGeAlD
Ketamine—TACR1—central nervous system—epilepsy syndrome	0.000139	0.00458	CbGeAlD
Ketamine—GRIN2A—head—epilepsy syndrome	0.000139	0.00457	CbGeAlD
Ketamine—OPRM1—telencephalon—epilepsy syndrome	0.000135	0.00446	CbGeAlD
Ketamine—GRIN2D—brain—epilepsy syndrome	0.000135	0.00446	CbGeAlD
Ketamine—GRIN2A—nervous system—epilepsy syndrome	0.000131	0.00434	CbGeAlD
Ketamine—GRIN3A—brain—epilepsy syndrome	0.000127	0.00419	CbGeAlD
Ketamine—GRIN2A—central nervous system—epilepsy syndrome	0.000127	0.00417	CbGeAlD
Ketamine—GRIN2A—cerebellum—epilepsy syndrome	0.000124	0.00408	CbGeAlD
Ketamine—OPRD1—head—epilepsy syndrome	0.000124	0.00408	CbGeAlD
Ketamine—GRIN1—brain—epilepsy syndrome	0.000121	0.00397	CbGeAlD
Ketamine—OPRK1—head—epilepsy syndrome	0.000119	0.00391	CbGeAlD
Ketamine—OPRD1—nervous system—epilepsy syndrome	0.000117	0.00386	CbGeAlD
Ketamine—GRIN2B—brain—epilepsy syndrome	0.000115	0.00379	CbGeAlD
Ketamine—OPRD1—central nervous system—epilepsy syndrome	0.000113	0.00372	CbGeAlD
Ketamine—OPRK1—nervous system—epilepsy syndrome	0.000112	0.0037	CbGeAlD
Ketamine—SLC6A2—brainstem—epilepsy syndrome	0.000112	0.00368	CbGeAlD
Ketamine—TACR1—brain—epilepsy syndrome	0.00011	0.00363	CbGeAlD
Ketamine—OPRK1—central nervous system—epilepsy syndrome	0.000108	0.00357	CbGeAlD
Ketamine—Shock—Phenobarbital—epilepsy syndrome	0.000108	0.00185	CcSEcCtD
Ketamine—Decreased appetite—Trimethadione—epilepsy syndrome	0.000108	0.00185	CcSEcCtD
Ketamine—SLC6A2—forebrain—epilepsy syndrome	0.000108	0.00355	CbGeAlD
Ketamine—OPRK1—cerebellum—epilepsy syndrome	0.000106	0.00349	CbGeAlD
Ketamine—Bradycardia—Diazepam—epilepsy syndrome	0.000104	0.00179	CcSEcCtD
Ketamine—Anorexia—Rufinamide—epilepsy syndrome	0.000103	0.00176	CcSEcCtD
Ketamine—Hypotension—Phenobarbital—epilepsy syndrome	0.000103	0.00176	CcSEcCtD
Ketamine—Arrhythmia—Propofol—epilepsy syndrome	0.000102	0.00175	CcSEcCtD
Ketamine—DRD2—brainstem—epilepsy syndrome	0.000102	0.00336	CbGeAlD
Ketamine—Bladder pain—Gabapentin—epilepsy syndrome	0.000102	0.00174	CcSEcCtD
Ketamine—Bradycardia—Felbamate—epilepsy syndrome	0.000101	0.00173	CcSEcCtD
Ketamine—GRIN2A—brain—epilepsy syndrome	0.000101	0.00331	CbGeAlD
Ketamine—Erythema—Propofol—epilepsy syndrome	9.98e-05	0.00171	CcSEcCtD
Ketamine—Shock—Lacosamide—epilepsy syndrome	9.97e-05	0.00171	CcSEcCtD
Ketamine—SLC6A2—telencephalon—epilepsy syndrome	9.91e-05	0.00327	CbGeAlD
Ketamine—Bradycardia—Zonisamide—epilepsy syndrome	9.89e-05	0.00169	CcSEcCtD
Ketamine—Diplopia—Valproic Acid—epilepsy syndrome	9.86e-05	0.00169	CcSEcCtD
Ketamine—DRD2—forebrain—epilepsy syndrome	9.82e-05	0.00324	CbGeAlD
Ketamine—Erythema—Midazolam—epilepsy syndrome	9.76e-05	0.00167	CcSEcCtD
Ketamine—OPRM1—midbrain—epilepsy syndrome	9.72e-05	0.00321	CbGeAlD
Ketamine—Muscle twitching—Topiramate—epilepsy syndrome	9.64e-05	0.00165	CcSEcCtD
Ketamine—OPRM1—spinal cord—epilepsy syndrome	9.49e-05	0.00313	CbGeAlD
Ketamine—Bradycardia—Phenytoin—epilepsy syndrome	9.47e-05	0.00162	CcSEcCtD
Ketamine—Bradycardia—Oxcarbazepine—epilepsy syndrome	9.42e-05	0.00161	CcSEcCtD
Ketamine—Pain—Phenobarbital—epilepsy syndrome	9.4e-05	0.00161	CcSEcCtD
Ketamine—Decreased appetite—Rufinamide—epilepsy syndrome	9.38e-05	0.00161	CcSEcCtD
Ketamine—Anorexia—Clobazam—epilepsy syndrome	9.37e-05	0.00161	CcSEcCtD
Ketamine—Vomiting—Amobarbital—epilepsy syndrome	9.31e-05	0.0016	CcSEcCtD
Ketamine—Convulsion—Acetazolamide—epilepsy syndrome	9.31e-05	0.00159	CcSEcCtD
Ketamine—Cystitis noninfective—Topiramate—epilepsy syndrome	9.25e-05	0.00158	CcSEcCtD
Ketamine—Rash—Amobarbital—epilepsy syndrome	9.24e-05	0.00158	CcSEcCtD
Ketamine—Dermatitis—Amobarbital—epilepsy syndrome	9.23e-05	0.00158	CcSEcCtD
Ketamine—Vision blurred—Midazolam—epilepsy syndrome	9.2e-05	0.00158	CcSEcCtD
Ketamine—Salivary hypersecretion—Topiramate—epilepsy syndrome	9.2e-05	0.00158	CcSEcCtD
Ketamine—Hypotension—Clobazam—epilepsy syndrome	9.19e-05	0.00157	CcSEcCtD
Ketamine—Arrhythmia—Diazepam—epilepsy syndrome	9.16e-05	0.00157	CcSEcCtD
Ketamine—Cystitis—Topiramate—epilepsy syndrome	9.14e-05	0.00157	CcSEcCtD
Ketamine—Vision blurred—Levetiracetam—epilepsy syndrome	9.08e-05	0.00156	CcSEcCtD
Ketamine—Bradycardia—Carbamazepine—epilepsy syndrome	9.04e-05	0.00155	CcSEcCtD
Ketamine—DRD2—telencephalon—epilepsy syndrome	9.03e-05	0.00298	CbGeAlD
Ketamine—Vomiting—Primidone—epilepsy syndrome	8.97e-05	0.00154	CcSEcCtD
Ketamine—OPRD1—brain—epilepsy syndrome	8.96e-05	0.00295	CbGeAlD
Ketamine—Erythema—Diazepam—epilepsy syndrome	8.93e-05	0.00153	CcSEcCtD
Ketamine—Diplopia—Pregabalin—epilepsy syndrome	8.91e-05	0.00153	CcSEcCtD
Ketamine—Rash—Primidone—epilepsy syndrome	8.9e-05	0.00152	CcSEcCtD
Ketamine—Dermatitis—Primidone—epilepsy syndrome	8.89e-05	0.00152	CcSEcCtD
Ketamine—Anaphylactic shock—Acetazolamide—epilepsy syndrome	8.77e-05	0.0015	CcSEcCtD
Ketamine—Nausea—Amobarbital—epilepsy syndrome	8.7e-05	0.00149	CcSEcCtD
Ketamine—Convulsion—Propofol—epilepsy syndrome	8.64e-05	0.00148	CcSEcCtD
Ketamine—Shock—Acetazolamide—epilepsy syndrome	8.62e-05	0.00148	CcSEcCtD
Ketamine—OPRK1—brain—epilepsy syndrome	8.59e-05	0.00283	CbGeAlD
Ketamine—Bladder pain—Topiramate—epilepsy syndrome	8.56e-05	0.00147	CcSEcCtD
Ketamine—Decreased appetite—Clobazam—epilepsy syndrome	8.55e-05	0.00146	CcSEcCtD
Ketamine—Vision blurred—Vigabatrin—epilepsy syndrome	8.55e-05	0.00146	CcSEcCtD
Ketamine—OPRM1—head—epilepsy syndrome	8.43e-05	0.00278	CbGeAlD
Ketamine—Vision blurred—Diazepam—epilepsy syndrome	8.41e-05	0.00144	CcSEcCtD
Ketamine—Nausea—Primidone—epilepsy syndrome	8.38e-05	0.00144	CcSEcCtD
Ketamine—Convulsion—Levetiracetam—epilepsy syndrome	8.35e-05	0.00143	CcSEcCtD
Ketamine—Arrhythmia—Oxcarbazepine—epilepsy syndrome	8.26e-05	0.00142	CcSEcCtD
Ketamine—Diplopia—Gabapentin—epilepsy syndrome	8.17e-05	0.0014	CcSEcCtD
Ketamine—Anaphylactic shock—Propofol—epilepsy syndrome	8.14e-05	0.00139	CcSEcCtD
Ketamine—Convulsion—Fosphenytoin—epilepsy syndrome	8.06e-05	0.00138	CcSEcCtD
Ketamine—Shock—Propofol—epilepsy syndrome	8.01e-05	0.00137	CcSEcCtD
Ketamine—OPRM1—nervous system—epilepsy syndrome	7.99e-05	0.00264	CbGeAlD
Ketamine—Anaphylactic shock—Midazolam—epilepsy syndrome	7.97e-05	0.00136	CcSEcCtD
Ketamine—Arrhythmia—Carbamazepine—epilepsy syndrome	7.93e-05	0.00136	CcSEcCtD
Ketamine—Vomiting—Trimethadione—epilepsy syndrome	7.89e-05	0.00135	CcSEcCtD
Ketamine—Convulsion—Vigabatrin—epilepsy syndrome	7.86e-05	0.00135	CcSEcCtD
Ketamine—Shock—Midazolam—epilepsy syndrome	7.84e-05	0.00134	CcSEcCtD
Ketamine—Rash—Trimethadione—epilepsy syndrome	7.83e-05	0.00134	CcSEcCtD
Ketamine—Dermatitis—Trimethadione—epilepsy syndrome	7.82e-05	0.00134	CcSEcCtD
Ketamine—SLC6A2—medulla oblongata—epilepsy syndrome	7.79e-05	0.00257	CbGeAlD
Ketamine—Erythema—Carbamazepine—epilepsy syndrome	7.73e-05	0.00132	CcSEcCtD
Ketamine—OPRM1—central nervous system—epilepsy syndrome	7.7e-05	0.00254	CbGeAlD
Ketamine—Vision blurred—Clonazepam—epilepsy syndrome	7.68e-05	0.00132	CcSEcCtD
Ketamine—Decreased appetite—Acetazolamide—epilepsy syndrome	7.62e-05	0.00131	CcSEcCtD
Ketamine—Hypotension—Propofol—epilepsy syndrome	7.61e-05	0.0013	CcSEcCtD
Ketamine—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	7.59e-05	0.0013	CcSEcCtD
Ketamine—Vision blurred—Oxcarbazepine—epilepsy syndrome	7.59e-05	0.0013	CcSEcCtD
Ketamine—Anorexia—Levetiracetam—epilepsy syndrome	7.5e-05	0.00128	CcSEcCtD
Ketamine—Shock—Fosphenytoin—epilepsy syndrome	7.47e-05	0.00128	CcSEcCtD
Ketamine—Erythema—Lamotrigine—epilepsy syndrome	7.47e-05	0.00128	CcSEcCtD
Ketamine—Hypotension—Midazolam—epilepsy syndrome	7.44e-05	0.00128	CcSEcCtD
Ketamine—Nausea—Trimethadione—epilepsy syndrome	7.37e-05	0.00126	CcSEcCtD
Ketamine—Convulsion—Zonisamide—epilepsy syndrome	7.33e-05	0.00126	CcSEcCtD
Ketamine—Anaphylactic shock—Diazepam—epilepsy syndrome	7.29e-05	0.00125	CcSEcCtD
Ketamine—Vision blurred—Carbamazepine—epilepsy syndrome	7.28e-05	0.00125	CcSEcCtD
Ketamine—Anorexia—Fosphenytoin—epilepsy syndrome	7.24e-05	0.00124	CcSEcCtD
Ketamine—PTGS1—forebrain—epilepsy syndrome	7.18e-05	0.00237	CbGeAlD
Ketamine—Shock—Diazepam—epilepsy syndrome	7.17e-05	0.00123	CcSEcCtD
Ketamine—Hypotension—Fosphenytoin—epilepsy syndrome	7.09e-05	0.00122	CcSEcCtD
Ketamine—Anaphylactic shock—Felbamate—epilepsy syndrome	7.05e-05	0.00121	CcSEcCtD
Ketamine—Vision blurred—Lamotrigine—epilepsy syndrome	7.04e-05	0.00121	CcSEcCtD
Ketamine—Convulsion—Phenytoin—epilepsy syndrome	7.02e-05	0.0012	CcSEcCtD
Ketamine—Vomiting—Phenobarbital—epilepsy syndrome	6.99e-05	0.0012	CcSEcCtD
Ketamine—Convulsion—Oxcarbazepine—epilepsy syndrome	6.98e-05	0.0012	CcSEcCtD
Ketamine—Pain—Propofol—epilepsy syndrome	6.96e-05	0.00119	CcSEcCtD
Ketamine—Anorexia—Diazepam—epilepsy syndrome	6.95e-05	0.00119	CcSEcCtD
Ketamine—Bradycardia—Valproic Acid—epilepsy syndrome	6.94e-05	0.00119	CcSEcCtD
Ketamine—Rash—Phenobarbital—epilepsy syndrome	6.93e-05	0.00119	CcSEcCtD
Ketamine—Dermatitis—Phenobarbital—epilepsy syndrome	6.93e-05	0.00119	CcSEcCtD
Ketamine—Diplopia—Topiramate—epilepsy syndrome	6.87e-05	0.00118	CcSEcCtD
Ketamine—Vomiting—Rufinamide—epilepsy syndrome	6.86e-05	0.00118	CcSEcCtD
Ketamine—Decreased appetite—Levetiracetam—epilepsy syndrome	6.84e-05	0.00117	CcSEcCtD
Ketamine—Pain—Midazolam—epilepsy syndrome	6.81e-05	0.00117	CcSEcCtD
Ketamine—Hypotension—Diazepam—epilepsy syndrome	6.81e-05	0.00117	CcSEcCtD
Ketamine—Rash—Rufinamide—epilepsy syndrome	6.8e-05	0.00117	CcSEcCtD
Ketamine—Dermatitis—Rufinamide—epilepsy syndrome	6.8e-05	0.00116	CcSEcCtD
Ketamine—Shock—Zonisamide—epilepsy syndrome	6.79e-05	0.00116	CcSEcCtD
Ketamine—Pain—Levetiracetam—epilepsy syndrome	6.73e-05	0.00115	CcSEcCtD
Ketamine—Anorexia—Felbamate—epilepsy syndrome	6.72e-05	0.00115	CcSEcCtD
Ketamine—Convulsion—Carbamazepine—epilepsy syndrome	6.7e-05	0.00115	CcSEcCtD
Ketamine—Anaphylactic shock—Clonazepam—epilepsy syndrome	6.65e-05	0.00114	CcSEcCtD
Ketamine—Anaphylactic shock—Phenytoin—epilepsy syndrome	6.61e-05	0.00113	CcSEcCtD
Ketamine—PTGS1—telencephalon—epilepsy syndrome	6.6e-05	0.00218	CbGeAlD
Ketamine—Decreased appetite—Fosphenytoin—epilepsy syndrome	6.6e-05	0.00113	CcSEcCtD
Ketamine—Hypotension—Felbamate—epilepsy syndrome	6.59e-05	0.00113	CcSEcCtD
Ketamine—Anorexia—Zonisamide—epilepsy syndrome	6.58e-05	0.00113	CcSEcCtD
Ketamine—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	6.57e-05	0.00113	CcSEcCtD
Ketamine—Nausea—Phenobarbital—epilepsy syndrome	6.53e-05	0.00112	CcSEcCtD
Ketamine—Shock—Phenytoin—epilepsy syndrome	6.5e-05	0.00111	CcSEcCtD
Ketamine—DRD2—midbrain—epilepsy syndrome	6.49e-05	0.00214	CbGeAlD
Ketamine—Convulsion—Lamotrigine—epilepsy syndrome	6.47e-05	0.00111	CcSEcCtD
Ketamine—Shock—Oxcarbazepine—epilepsy syndrome	6.47e-05	0.00111	CcSEcCtD
Ketamine—Hypotension—Zonisamide—epilepsy syndrome	6.45e-05	0.00111	CcSEcCtD
Ketamine—Vomiting—Lacosamide—epilepsy syndrome	6.44e-05	0.0011	CcSEcCtD
Ketamine—Decreased appetite—Vigabatrin—epilepsy syndrome	6.43e-05	0.0011	CcSEcCtD
Ketamine—Nausea—Rufinamide—epilepsy syndrome	6.41e-05	0.0011	CcSEcCtD
Ketamine—Rash—Lacosamide—epilepsy syndrome	6.39e-05	0.00109	CcSEcCtD
Ketamine—Dermatitis—Lacosamide—epilepsy syndrome	6.38e-05	0.00109	CcSEcCtD
Ketamine—Anorexia—Clonazepam—epilepsy syndrome	6.34e-05	0.00109	CcSEcCtD
Ketamine—Decreased appetite—Diazepam—epilepsy syndrome	6.33e-05	0.00109	CcSEcCtD
Ketamine—Pain—Vigabatrin—epilepsy syndrome	6.33e-05	0.00108	CcSEcCtD
Ketamine—Anaphylactic shock—Carbamazepine—epilepsy syndrome	6.31e-05	0.00108	CcSEcCtD
Ketamine—Anorexia—Phenytoin—epilepsy syndrome	6.3e-05	0.00108	CcSEcCtD
Ketamine—Bradycardia—Pregabalin—epilepsy syndrome	6.28e-05	0.00108	CcSEcCtD
Ketamine—Anorexia—Oxcarbazepine—epilepsy syndrome	6.27e-05	0.00107	CcSEcCtD
Ketamine—Vomiting—Clobazam—epilepsy syndrome	6.25e-05	0.00107	CcSEcCtD
Ketamine—Pain—Diazepam—epilepsy syndrome	6.23e-05	0.00107	CcSEcCtD
Ketamine—Hypotension—Clonazepam—epilepsy syndrome	6.22e-05	0.00106	CcSEcCtD
Ketamine—Shock—Carbamazepine—epilepsy syndrome	6.21e-05	0.00106	CcSEcCtD
Ketamine—Rash—Clobazam—epilepsy syndrome	6.2e-05	0.00106	CcSEcCtD
Ketamine—Dermatitis—Clobazam—epilepsy syndrome	6.2e-05	0.00106	CcSEcCtD
Ketamine—Hypotension—Phenytoin—epilepsy syndrome	6.17e-05	0.00106	CcSEcCtD
Ketamine—SLC6A2—head—epilepsy syndrome	6.17e-05	0.00204	CbGeAlD
Ketamine—Hypotension—Oxcarbazepine—epilepsy syndrome	6.14e-05	0.00105	CcSEcCtD
Ketamine—Decreased appetite—Felbamate—epilepsy syndrome	6.13e-05	0.00105	CcSEcCtD
Ketamine—OPRM1—brain—epilepsy syndrome	6.11e-05	0.00201	CbGeAlD
Ketamine—Arrhythmia—Valproic Acid—epilepsy syndrome	6.09e-05	0.00104	CcSEcCtD
Ketamine—Pain—Felbamate—epilepsy syndrome	6.03e-05	0.00103	CcSEcCtD
Ketamine—Nausea—Lacosamide—epilepsy syndrome	6.02e-05	0.00103	CcSEcCtD
Ketamine—Anorexia—Carbamazepine—epilepsy syndrome	6.01e-05	0.00103	CcSEcCtD
Ketamine—Decreased appetite—Zonisamide—epilepsy syndrome	6e-05	0.00103	CcSEcCtD
Ketamine—Shock—Lamotrigine—epilepsy syndrome	6e-05	0.00103	CcSEcCtD
Ketamine—Hypotension—Carbamazepine—epilepsy syndrome	5.89e-05	0.00101	CcSEcCtD
Ketamine—SLC6A2—nervous system—epilepsy syndrome	5.85e-05	0.00193	CbGeAlD
Ketamine—Nausea—Clobazam—epilepsy syndrome	5.84e-05	0.001	CcSEcCtD
Ketamine—Anorexia—Lamotrigine—epilepsy syndrome	5.81e-05	0.000996	CcSEcCtD
Ketamine—Decreased appetite—Clonazepam—epilepsy syndrome	5.78e-05	0.000991	CcSEcCtD
Ketamine—Bradycardia—Gabapentin—epilepsy syndrome	5.75e-05	0.000986	CcSEcCtD
Ketamine—Decreased appetite—Phenytoin—epilepsy syndrome	5.74e-05	0.000984	CcSEcCtD
Ketamine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.000979	CcSEcCtD
Ketamine—Pain—Clonazepam—epilepsy syndrome	5.69e-05	0.000975	CcSEcCtD
Ketamine—SLC6A2—central nervous system—epilepsy syndrome	5.64e-05	0.00186	CbGeAlD
Ketamine—DRD2—head—epilepsy syndrome	5.63e-05	0.00185	CbGeAlD
Ketamine—Pain—Oxcarbazepine—epilepsy syndrome	5.62e-05	0.000963	CcSEcCtD
Ketamine—Vision blurred—Valproic Acid—epilepsy syndrome	5.59e-05	0.000958	CcSEcCtD
Ketamine—Vomiting—Acetazolamide—epilepsy syndrome	5.57e-05	0.000955	CcSEcCtD
Ketamine—Arrhythmia—Pregabalin—epilepsy syndrome	5.51e-05	0.000943	CcSEcCtD
Ketamine—Decreased appetite—Carbamazepine—epilepsy syndrome	5.48e-05	0.000939	CcSEcCtD
Ketamine—Pain—Carbamazepine—epilepsy syndrome	5.39e-05	0.000924	CcSEcCtD
Ketamine—DRD2—nervous system—epilepsy syndrome	5.33e-05	0.00176	CbGeAlD
Ketamine—Decreased appetite—Lamotrigine—epilepsy syndrome	5.3e-05	0.000908	CcSEcCtD
Ketamine—Pain—Lamotrigine—epilepsy syndrome	5.21e-05	0.000893	CcSEcCtD
Ketamine—Nausea—Acetazolamide—epilepsy syndrome	5.21e-05	0.000892	CcSEcCtD
Ketamine—Vomiting—Propofol—epilepsy syndrome	5.18e-05	0.000887	CcSEcCtD
Ketamine—DRD2—central nervous system—epilepsy syndrome	5.13e-05	0.00169	CbGeAlD
Ketamine—Rash—Propofol—epilepsy syndrome	5.13e-05	0.00088	CcSEcCtD
Ketamine—Dermatitis—Propofol—epilepsy syndrome	5.13e-05	0.000879	CcSEcCtD
Ketamine—Vomiting—Midazolam—epilepsy syndrome	5.06e-05	0.000868	CcSEcCtD
Ketamine—Vision blurred—Pregabalin—epilepsy syndrome	5.06e-05	0.000866	CcSEcCtD
Ketamine—Rash—Midazolam—epilepsy syndrome	5.02e-05	0.000861	CcSEcCtD
Ketamine—DRD2—cerebellum—epilepsy syndrome	5.02e-05	0.00165	CbGeAlD
Ketamine—Dermatitis—Midazolam—epilepsy syndrome	5.02e-05	0.00086	CcSEcCtD
Ketamine—Vomiting—Levetiracetam—epilepsy syndrome	5e-05	0.000857	CcSEcCtD
Ketamine—Rash—Levetiracetam—epilepsy syndrome	4.96e-05	0.00085	CcSEcCtD
Ketamine—Dermatitis—Levetiracetam—epilepsy syndrome	4.96e-05	0.000849	CcSEcCtD
Ketamine—Erythema—Gabapentin—epilepsy syndrome	4.92e-05	0.000843	CcSEcCtD
Ketamine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	4.84e-05	0.00083	CcSEcCtD
Ketamine—Bradycardia—Topiramate—epilepsy syndrome	4.84e-05	0.000829	CcSEcCtD
Ketamine—Nausea—Propofol—epilepsy syndrome	4.84e-05	0.000829	CcSEcCtD
Ketamine—Vomiting—Fosphenytoin—epilepsy syndrome	4.83e-05	0.000827	CcSEcCtD
Ketamine—Rash—Fosphenytoin—epilepsy syndrome	4.79e-05	0.00082	CcSEcCtD
Ketamine—Dermatitis—Fosphenytoin—epilepsy syndrome	4.78e-05	0.000819	CcSEcCtD
Ketamine—Nausea—Midazolam—epilepsy syndrome	4.73e-05	0.000811	CcSEcCtD
Ketamine—Vomiting—Vigabatrin—epilepsy syndrome	4.71e-05	0.000806	CcSEcCtD
Ketamine—Nausea—Levetiracetam—epilepsy syndrome	4.67e-05	0.000801	CcSEcCtD
Ketamine—Rash—Vigabatrin—epilepsy syndrome	4.67e-05	0.000799	CcSEcCtD
Ketamine—Dermatitis—Vigabatrin—epilepsy syndrome	4.66e-05	0.000799	CcSEcCtD
Ketamine—Convulsion—Pregabalin—epilepsy syndrome	4.65e-05	0.000796	CcSEcCtD
Ketamine—Vision blurred—Gabapentin—epilepsy syndrome	4.64e-05	0.000794	CcSEcCtD
Ketamine—Vomiting—Diazepam—epilepsy syndrome	4.63e-05	0.000794	CcSEcCtD
Ketamine—PTGS1—spinal cord—epilepsy syndrome	4.63e-05	0.00153	CbGeAlD
Ketamine—Anorexia—Valproic Acid—epilepsy syndrome	4.62e-05	0.000791	CcSEcCtD
Ketamine—Rash—Diazepam—epilepsy syndrome	4.59e-05	0.000787	CcSEcCtD
Ketamine—Dermatitis—Diazepam—epilepsy syndrome	4.59e-05	0.000786	CcSEcCtD
Ketamine—CYP2B6—head—epilepsy syndrome	4.55e-05	0.0015	CbGeAlD
Ketamine—Hypotension—Valproic Acid—epilepsy syndrome	4.53e-05	0.000775	CcSEcCtD
Ketamine—Nausea—Fosphenytoin—epilepsy syndrome	4.51e-05	0.000773	CcSEcCtD
Ketamine—Vomiting—Felbamate—epilepsy syndrome	4.48e-05	0.000768	CcSEcCtD
Ketamine—SLC6A2—brain—epilepsy syndrome	4.47e-05	0.00147	CbGeAlD
Ketamine—Rash—Felbamate—epilepsy syndrome	4.45e-05	0.000762	CcSEcCtD
Ketamine—Dermatitis—Felbamate—epilepsy syndrome	4.44e-05	0.000761	CcSEcCtD
Ketamine—Nausea—Vigabatrin—epilepsy syndrome	4.4e-05	0.000753	CcSEcCtD
Ketamine—Vomiting—Zonisamide—epilepsy syndrome	4.39e-05	0.000752	CcSEcCtD
Ketamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.38e-05	0.00075	CcSEcCtD
Ketamine—Rash—Zonisamide—epilepsy syndrome	4.35e-05	0.000746	CcSEcCtD
Ketamine—Dermatitis—Zonisamide—epilepsy syndrome	4.35e-05	0.000745	CcSEcCtD
Ketamine—Nausea—Diazepam—epilepsy syndrome	4.33e-05	0.000741	CcSEcCtD
Ketamine—CYP2B6—nervous system—epilepsy syndrome	4.31e-05	0.00142	CbGeAlD
Ketamine—Shock—Pregabalin—epilepsy syndrome	4.31e-05	0.000738	CcSEcCtD
Ketamine—Convulsion—Gabapentin—epilepsy syndrome	4.26e-05	0.00073	CcSEcCtD
Ketamine—ABCB1—forebrain—epilepsy syndrome	4.25e-05	0.0014	CbGeAlD
Ketamine—Vomiting—Clonazepam—epilepsy syndrome	4.23e-05	0.000725	CcSEcCtD
Ketamine—Decreased appetite—Valproic Acid—epilepsy syndrome	4.21e-05	0.000721	CcSEcCtD
Ketamine—Vomiting—Phenytoin—epilepsy syndrome	4.2e-05	0.00072	CcSEcCtD
Ketamine—Rash—Clonazepam—epilepsy syndrome	4.19e-05	0.000719	CcSEcCtD
Ketamine—Dermatitis—Clonazepam—epilepsy syndrome	4.19e-05	0.000718	CcSEcCtD
Ketamine—Nausea—Felbamate—epilepsy syndrome	4.19e-05	0.000718	CcSEcCtD
Ketamine—Vomiting—Oxcarbazepine—epilepsy syndrome	4.18e-05	0.000716	CcSEcCtD
Ketamine—Anorexia—Pregabalin—epilepsy syndrome	4.17e-05	0.000715	CcSEcCtD
Ketamine—Rash—Phenytoin—epilepsy syndrome	4.17e-05	0.000714	CcSEcCtD
Ketamine—Dermatitis—Phenytoin—epilepsy syndrome	4.16e-05	0.000713	CcSEcCtD
Ketamine—CYP2B6—central nervous system—epilepsy syndrome	4.15e-05	0.00137	CbGeAlD
Ketamine—Rash—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.00071	CcSEcCtD
Ketamine—Pain—Valproic Acid—epilepsy syndrome	4.14e-05	0.00071	CcSEcCtD
Ketamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000709	CcSEcCtD
Ketamine—Erythema—Topiramate—epilepsy syndrome	4.14e-05	0.000709	CcSEcCtD
Ketamine—PTGS1—head—epilepsy syndrome	4.11e-05	0.00136	CbGeAlD
Ketamine—Nausea—Zonisamide—epilepsy syndrome	4.1e-05	0.000702	CcSEcCtD
Ketamine—Hypotension—Pregabalin—epilepsy syndrome	4.09e-05	0.000701	CcSEcCtD
Ketamine—DRD2—brain—epilepsy syndrome	4.08e-05	0.00134	CbGeAlD
Ketamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.02e-05	0.000688	CcSEcCtD
Ketamine—Vomiting—Carbamazepine—epilepsy syndrome	4.01e-05	0.000687	CcSEcCtD
Ketamine—Rash—Carbamazepine—epilepsy syndrome	3.98e-05	0.000681	CcSEcCtD
Ketamine—Dermatitis—Carbamazepine—epilepsy syndrome	3.97e-05	0.000681	CcSEcCtD
Ketamine—Nausea—Clonazepam—epilepsy syndrome	3.95e-05	0.000677	CcSEcCtD
Ketamine—Shock—Gabapentin—epilepsy syndrome	3.95e-05	0.000677	CcSEcCtD
Ketamine—Nausea—Phenytoin—epilepsy syndrome	3.92e-05	0.000672	CcSEcCtD
Ketamine—ABCB1—telencephalon—epilepsy syndrome	3.9e-05	0.00129	CbGeAlD
Ketamine—Nausea—Oxcarbazepine—epilepsy syndrome	3.9e-05	0.000669	CcSEcCtD
Ketamine—Vision blurred—Topiramate—epilepsy syndrome	3.9e-05	0.000668	CcSEcCtD
Ketamine—PTGS1—nervous system—epilepsy syndrome	3.9e-05	0.00129	CbGeAlD
Ketamine—Vomiting—Lamotrigine—epilepsy syndrome	3.88e-05	0.000664	CcSEcCtD
Ketamine—Rash—Lamotrigine—epilepsy syndrome	3.84e-05	0.000658	CcSEcCtD
Ketamine—Dermatitis—Lamotrigine—epilepsy syndrome	3.84e-05	0.000658	CcSEcCtD
Ketamine—Anorexia—Gabapentin—epilepsy syndrome	3.83e-05	0.000656	CcSEcCtD
Ketamine—Decreased appetite—Pregabalin—epilepsy syndrome	3.81e-05	0.000652	CcSEcCtD
Ketamine—PTGS1—central nervous system—epilepsy syndrome	3.75e-05	0.00124	CbGeAlD
Ketamine—Hypotension—Gabapentin—epilepsy syndrome	3.75e-05	0.000643	CcSEcCtD
Ketamine—Nausea—Carbamazepine—epilepsy syndrome	3.75e-05	0.000642	CcSEcCtD
Ketamine—Pain—Pregabalin—epilepsy syndrome	3.74e-05	0.000642	CcSEcCtD
Ketamine—CYP2C8—brain—epilepsy syndrome	3.68e-05	0.00121	CbGeAlD
Ketamine—Nausea—Lamotrigine—epilepsy syndrome	3.62e-05	0.00062	CcSEcCtD
Ketamine—Convulsion—Topiramate—epilepsy syndrome	3.59e-05	0.000614	CcSEcCtD
Ketamine—Decreased appetite—Gabapentin—epilepsy syndrome	3.49e-05	0.000598	CcSEcCtD
Ketamine—Pain—Gabapentin—epilepsy syndrome	3.43e-05	0.000588	CcSEcCtD
Ketamine—Shock—Topiramate—epilepsy syndrome	3.32e-05	0.000569	CcSEcCtD
Ketamine—CYP2B6—brain—epilepsy syndrome	3.3e-05	0.00109	CbGeAlD
Ketamine—CYP3A4—nervous system—epilepsy syndrome	3.26e-05	0.00107	CbGeAlD
Ketamine—Anorexia—Topiramate—epilepsy syndrome	3.22e-05	0.000552	CcSEcCtD
Ketamine—Hypotension—Topiramate—epilepsy syndrome	3.16e-05	0.000541	CcSEcCtD
Ketamine—CYP3A4—central nervous system—epilepsy syndrome	3.14e-05	0.00103	CbGeAlD
Ketamine—Vomiting—Valproic Acid—epilepsy syndrome	3.08e-05	0.000528	CcSEcCtD
Ketamine—ABCB1—medulla oblongata—epilepsy syndrome	3.07e-05	0.00101	CbGeAlD
Ketamine—Rash—Valproic Acid—epilepsy syndrome	3.05e-05	0.000523	CcSEcCtD
Ketamine—Dermatitis—Valproic Acid—epilepsy syndrome	3.05e-05	0.000523	CcSEcCtD
Ketamine—PTGS1—brain—epilepsy syndrome	2.98e-05	0.000983	CbGeAlD
Ketamine—Decreased appetite—Topiramate—epilepsy syndrome	2.94e-05	0.000503	CcSEcCtD
Ketamine—Pain—Topiramate—epilepsy syndrome	2.89e-05	0.000495	CcSEcCtD
Ketamine—Nausea—Valproic Acid—epilepsy syndrome	2.88e-05	0.000493	CcSEcCtD
Ketamine—ABCB1—midbrain—epilepsy syndrome	2.8e-05	0.000924	CbGeAlD
Ketamine—Vomiting—Pregabalin—epilepsy syndrome	2.78e-05	0.000477	CcSEcCtD
Ketamine—Rash—Pregabalin—epilepsy syndrome	2.76e-05	0.000473	CcSEcCtD
Ketamine—Dermatitis—Pregabalin—epilepsy syndrome	2.76e-05	0.000473	CcSEcCtD
Ketamine—ABCB1—spinal cord—epilepsy syndrome	2.74e-05	0.000902	CbGeAlD
Ketamine—Nausea—Pregabalin—epilepsy syndrome	2.6e-05	0.000446	CcSEcCtD
Ketamine—Vomiting—Gabapentin—epilepsy syndrome	2.55e-05	0.000437	CcSEcCtD
Ketamine—Rash—Gabapentin—epilepsy syndrome	2.53e-05	0.000434	CcSEcCtD
Ketamine—Dermatitis—Gabapentin—epilepsy syndrome	2.53e-05	0.000433	CcSEcCtD
Ketamine—ABCB1—head—epilepsy syndrome	2.43e-05	0.000802	CbGeAlD
Ketamine—Nausea—Gabapentin—epilepsy syndrome	2.39e-05	0.000409	CcSEcCtD
Ketamine—ABCB1—nervous system—epilepsy syndrome	2.31e-05	0.00076	CbGeAlD
Ketamine—ABCB1—central nervous system—epilepsy syndrome	2.22e-05	0.000732	CbGeAlD
Ketamine—ABCB1—cerebellum—epilepsy syndrome	2.17e-05	0.000715	CbGeAlD
Ketamine—Vomiting—Topiramate—epilepsy syndrome	2.15e-05	0.000368	CcSEcCtD
Ketamine—Rash—Topiramate—epilepsy syndrome	2.13e-05	0.000365	CcSEcCtD
Ketamine—Dermatitis—Topiramate—epilepsy syndrome	2.13e-05	0.000365	CcSEcCtD
Ketamine—Nausea—Topiramate—epilepsy syndrome	2.01e-05	0.000344	CcSEcCtD
Ketamine—ABCB1—brain—epilepsy syndrome	1.76e-05	0.000581	CbGeAlD
Ketamine—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	8.4e-07	1.51e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	8.4e-07	1.51e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SRC—epilepsy syndrome	8.39e-07	1.5e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	8.35e-07	1.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.34e-07	1.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.34e-07	1.5e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	8.27e-07	1.48e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	8.22e-07	1.47e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HMOX1—epilepsy syndrome	8.22e-07	1.47e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—epilepsy syndrome	8.17e-07	1.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	8.17e-07	1.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	8.17e-07	1.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	8.17e-07	1.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SST—epilepsy syndrome	8.17e-07	1.47e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	8.16e-07	1.46e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	8.15e-07	1.46e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	8.15e-07	1.46e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CAT—epilepsy syndrome	8.11e-07	1.45e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	8.1e-07	1.45e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	8.04e-07	1.44e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	8.04e-07	1.44e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	8.02e-07	1.44e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	8.01e-07	1.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	7.99e-07	1.43e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	7.99e-07	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	7.96e-07	1.43e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	7.95e-07	1.43e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	7.91e-07	1.42e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ABCB1—epilepsy syndrome	7.89e-07	1.41e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.85e-07	1.41e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.84e-07	1.41e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	7.72e-07	1.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	7.68e-07	1.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	7.68e-07	1.38e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	7.67e-07	1.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	7.64e-07	1.37e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	7.64e-07	1.37e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	7.63e-07	1.37e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.63e-07	1.37e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	7.62e-07	1.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	7.61e-07	1.37e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.59e-07	1.36e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	7.54e-07	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	7.54e-07	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	7.54e-07	1.35e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TH—epilepsy syndrome	7.51e-07	1.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	7.51e-07	1.35e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	7.51e-07	1.35e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.48e-07	1.34e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	7.48e-07	1.34e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.47e-07	1.34e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.44e-07	1.33e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.43e-07	1.33e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.43e-07	1.33e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	7.35e-07	1.32e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GPX1—epilepsy syndrome	7.33e-07	1.32e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	7.32e-07	1.31e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	7.32e-07	1.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.22e-07	1.3e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	7.17e-07	1.29e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.16e-07	1.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	7.14e-07	1.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	7.14e-07	1.28e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	7.13e-07	1.28e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.11e-07	1.28e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.09e-07	1.27e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.09e-07	1.27e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	7.05e-07	1.26e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	7.02e-07	1.26e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	7.01e-07	1.26e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	6.96e-07	1.25e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	6.95e-07	1.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.94e-07	1.25e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.93e-07	1.24e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	6.89e-07	1.24e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	6.84e-07	1.23e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	6.81e-07	1.22e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.8e-07	1.22e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.8e-07	1.22e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	6.79e-07	1.22e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	6.76e-07	1.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.67e-07	1.2e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	6.64e-07	1.19e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.56e-07	1.18e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.54e-07	1.17e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	6.48e-07	1.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	6.47e-07	1.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	6.47e-07	1.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	6.46e-07	1.16e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	6.45e-07	1.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	6.45e-07	1.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	6.43e-07	1.15e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AGT—epilepsy syndrome	6.43e-07	1.15e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	6.42e-07	1.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	6.41e-07	1.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	6.39e-07	1.15e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.39e-07	1.15e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	6.38e-07	1.14e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TH—epilepsy syndrome	6.36e-07	1.14e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	6.32e-07	1.13e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOE—epilepsy syndrome	6.3e-07	1.13e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	6.28e-07	1.13e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	6.27e-07	1.12e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.26e-07	1.12e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.22e-07	1.12e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	6.19e-07	1.11e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	6.19e-07	1.11e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAT—epilepsy syndrome	6.19e-07	1.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.12e-07	1.1e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	6.02e-07	1.08e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	6.01e-07	1.08e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.96e-07	1.07e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.94e-07	1.07e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.93e-07	1.06e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.93e-07	1.06e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.92e-07	1.06e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	5.9e-07	1.06e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.89e-07	1.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	5.85e-07	1.05e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.82e-07	1.04e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.81e-07	1.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	5.69e-07	1.02e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	5.68e-07	1.02e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	5.67e-07	1.02e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	5.66e-07	1.02e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.62e-07	1.01e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	5.59e-07	1e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.56e-07	9.97e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TH—epilepsy syndrome	5.54e-07	9.94e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	5.53e-07	9.92e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	5.5e-07	9.88e-06	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.47e-07	9.82e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.47e-07	9.82e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	5.43e-07	9.74e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	5.42e-07	9.73e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—POMC—epilepsy syndrome	5.41e-07	9.71e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	5.41e-07	9.71e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.37e-07	9.64e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.37e-07	9.64e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	5.31e-07	9.53e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	5.31e-07	9.52e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	5.27e-07	9.46e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	5.27e-07	9.45e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	5.26e-07	9.44e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	5.25e-07	9.42e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAT—epilepsy syndrome	5.24e-07	9.39e-06	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—epilepsy syndrome	5.21e-07	9.35e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	5.19e-07	9.32e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TH—epilepsy syndrome	5.18e-07	9.28e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	5.17e-07	9.27e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	5.15e-07	9.24e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	5.12e-07	9.19e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.1e-07	9.14e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	5.09e-07	9.14e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	4.97e-07	8.92e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—epilepsy syndrome	4.93e-07	8.85e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AGT—epilepsy syndrome	4.91e-07	8.8e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	4.89e-07	8.78e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	4.89e-07	8.77e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOE—epilepsy syndrome	4.81e-07	8.62e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.8e-07	8.61e-06	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.8e-07	8.61e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	4.79e-07	8.59e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	4.76e-07	8.53e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	4.74e-07	8.5e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	4.72e-07	8.48e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	4.69e-07	8.42e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.62e-07	8.3e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	4.62e-07	8.29e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	4.6e-07	8.26e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAT—epilepsy syndrome	4.56e-07	8.18e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	4.52e-07	8.1e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	4.5e-07	8.07e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	4.49e-07	8.06e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	4.46e-07	7.99e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.38e-07	7.86e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	4.37e-07	7.84e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	4.36e-07	7.82e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.32e-07	7.75e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.32e-07	7.74e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.27e-07	7.66e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.26e-07	7.65e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.24e-07	7.61e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AGT—epilepsy syndrome	4.15e-07	7.45e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.15e-07	7.44e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	4.14e-07	7.43e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—POMC—epilepsy syndrome	4.13e-07	7.41e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.13e-07	7.4e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	4.11e-07	7.38e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOE—epilepsy syndrome	4.07e-07	7.3e-06	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.06e-07	7.28e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	4.04e-07	7.24e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.03e-07	7.22e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	4.02e-07	7.21e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	3.9e-07	7e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.85e-07	6.91e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.83e-07	6.87e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.8e-07	6.81e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—epilepsy syndrome	3.76e-07	6.75e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.68e-07	6.61e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.65e-07	6.54e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	3.64e-07	6.53e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.63e-07	6.51e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AGT—epilepsy syndrome	3.62e-07	6.49e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOE—epilepsy syndrome	3.54e-07	6.36e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	3.5e-07	6.28e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—POMC—epilepsy syndrome	3.5e-07	6.27e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.46e-07	6.21e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.43e-07	6.15e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TH—epilepsy syndrome	3.41e-07	6.12e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.41e-07	6.12e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.38e-07	6.06e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	3.38e-07	6.06e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.31e-07	5.94e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.31e-07	5.94e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	3.29e-07	5.91e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—epilepsy syndrome	3.19e-07	5.72e-06	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.07e-07	5.51e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.05e-07	5.46e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—POMC—epilepsy syndrome	3.05e-07	5.46e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.96e-07	5.31e-06	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.94e-07	5.27e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.88e-07	5.16e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.85e-07	5.11e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.84e-07	5.1e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.81e-07	5.04e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.79e-07	5.01e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.79e-07	5e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—epilepsy syndrome	2.78e-07	4.98e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.73e-07	4.91e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	4.76e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.59e-07	4.65e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.58e-07	4.64e-06	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	2.57e-07	4.62e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.54e-07	4.56e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.43e-07	4.36e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.27e-07	4.07e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.23e-07	4e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.18e-07	3.92e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.18e-07	3.9e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.17e-07	3.89e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.88e-07	3.37e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.71e-07	3.07e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	1.66e-07	2.97e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	2.96e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.5e-07	2.68e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.4e-07	2.51e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.22e-07	2.19e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.14e-07	2.05e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.52e-08	1.35e-06	CbGpPWpGaD
